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RESEARCH ARTICLE
Topical application of the anti-microbial chemical triclosan induces
immunomodulatory responses through the S100A8/A9-TLR4 pathway
Nikki B. Marshalla, Ewa Lukomskaa, Ajay P. Nayaka, Carrie M. Longa,b, Justin M. Hetticka and Stacey E. Andersona
aAllergy and Clinical Immunology Branch, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention,
Morgantown, WV, USA; bImmunology and Microbial Pathogenesis Graduate Program, West Virginia University School of Medicine, Morgantown,
WV, USA
ABSTRACT
The anti-microbial compound triclosan is incorporated into numerous consumer products and is detect-
able in the urine of 75% of the general United States population. Recent epidemiological studies report
positive associations with urinary triclosan levels and allergic disease. Although not sensitizing, earlier
studies previously found that repeated topical application of triclosan augments the allergic response to
ovalbumin (OVA) though a thymic stromal lymphopoietin (TSLP) pathway in mice. In the present study,
early immunological effects following triclosan exposure were further evaluated following topical applica-
tion in a murine model. These investigations revealed abundant expression of S100A8/A9, which report-
edly acts as an endogenous ligand for Toll-like Receptor 4 (TLR4), in skin tissues and in infiltrating
leukocytes during topical application of 0.75–3.0% triclosan. Expression of Tlr4 along with Tlr1, Tlr2 and
Tlr6 increased in skin tissues over time with triclosan exposure; high levels of TLR4 were expressed on
skin-infiltrating leukocytes. In vivo antibody blockade of the TLR4/MD-2 receptor complex impaired local
inflammatory responses after four days, as evidenced by decreased Il6, Tnfa, S100a8, S100a9, Tlr1, Tlr2, Tlr4
and Tlr6 expression in the skin and decreased lymph node cellularity and production of IL-4 and IL-13 by
lymph node T-cells. After nine days of triclosan exposure with TLR4/MD-2 blockade, impaired T-helper cell
type 2 (TH2) cytokine responses were sustained, but other early effects on skin and lymph node cellularity
were lost; this suggested alternative ligands/receptors compensated for the loss of TLR4 signaling. Taken
together, these data suggest the S100A8/A9-TLR4 pathway plays an early role in augmenting immunomo-
dulatory responses with triclosan exposure and support a role for the innate immune system in chemical
adjuvancy.
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Triclosan is a low molecular weight anti-microbial found in
numerous consumer products such as hand soaps, lotions, and
toothpaste, and is incorporated into items such as kitchen uten-
sils, clothing, furniture, and medical devices. It is so ubiquitous,
75% of the general United States population have detectable lev-
els in their urine (Calafat et al. 2008). Healthcare workers that
use triclosan-containing hand soaps in hospitals are found to
have increased urinary triclosan levels (MacIsaac et al. 2014),
suggesting occupational settings are a relevant site of exposure.
Over the last five years, epidemiological studies have identified
positive correlations between urinary levels of triclosan and sensi-
tization to food, aeroallergens and asthma perturbations (Clayton
et al. 2011; Savage et al. 2012, 2014; Bertelsen et al. 2013; Spanier
et al. 2014). Our laboratory has found that topical skin applica-
tion of triclosan augments allergic responses in a mouse ovalbu-
min (OVA) asthma model and although it does not act as an
allergic sensitizer (Anderson et al. 2012, 2015), it can induce
expression of the cytokine thymic stromal lymphopoietin (TSLP)
in the skin tissue that augments IL-4þ IL-13þT-helper cell type 2
(TH2) immune responses (Marshall et al. 2015). It was also
recently shown that IgE and IgG1 responses after epicutaneous
sensitization to peanut were augmented in mice with co-applica-
tion of 1% triclosan (Tobar et al. 2016). With increasing reports
that exposure to anti-microbial chemicals has the potential to
induce or augment allergic disease, further studies are needed to
help identify the mechanisms by which this occurs to help
understand ways to prevent or circumvent these effects.
The present study sought to identify innate immune factors
induced in the skin during repeated triclosan exposure that may
augment subsequent adaptive allergic responses. The results indi-
cated that repeated topical application of triclosan induced
expression of S100A8 (MRP-8; calgranulin A) and S100A9
(MRP-14; calgranulin B). These small calcium-binding proteins
fall under the category of alarmins, or damage-associated
molecular pattern proteins (DAMP) that are released by activated
or damaged cells. They can exist as both homodimers and
S100A8/A9 heterodimers also referred to as calprotectin. With
increasing concentrations of calcium, their target protein binding
sites are revealed, where they can act as pro-inflammatory factors
in innate immunity as well as broad-spectrum antimicrobials
through sequestration of Zn2þ and Mn2þ (Zackular et al. 2015).
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Interestingly, some of the functional effects of S100A8/A9
have been demonstrated to involve binding and activating of
Toll-like receptor 4 (TLR4)-Myd88 signaling. TLR4 is best known
for recognizing lipopolysaccharide (LPS) expressed on the outer
membrane of Gram-negative bacteria. It forms a complex with
myeloid differentiation protein-2 (MD-2) that helps to facilitate
clustering and internalization of the TLR4 receptor (Shimazu
et al. 1999; Kobayashi et al. 2006). This TLR4/MD-2 complex is
expressed by multiple cell types including endothelial, epithelial
and myeloid cells. Because the TLR4 pathway has been shown to
play a role in allergic inflammation (Miller & Modlin 2007), the
current study focused on identifying a potential role for the




BALB/cAnNTac mice (female, 6–8 week-of-age) were purchased
from Taconic (Germantown, NY). This strain has a TH2 bias and
is commonly used for investigations of allergic disease
(Woolhiser et al. 2000). Mice were group-housed in sanitized
HEPA-filtered cages containing sterilized hardwood chip bedding
and nesting enrichment materials in the AAALAC-accredited
NIOSH animal facility in Morgantown, WV. Mice were provided
NIH-31 modified irradiated rodent diet (Harlan, Indianapolis,
IN) and tap water ad libitum. Tissues were collected from the
mice immediately after euthanasia by CO2 overdose. All animal
procedures were reviewed and approved by the NIOSH Animal
Care and Use Committee.
Animal procedures
Triclosan (Calbiochem; CAS number 3380-34-5) was dissolved in
acetone (Sigma, St. Louis, MO) as a percent solution (weight/vol-
ume). Concentrations and timepoints used in these studies were
based on observations from previous studies (Marshall et al.
2015). Triclosan is typically incorporated into consumer products
in the range from 0.03 to 1.0%; thus, the present study used a
lower dose (0.75%) that falls within this range but does not pro-
duce overt skin irritation, as well as a high dose (3%) that produ-
ces transient irritation and more significant measurable effects.
Here, 25 ll of solution was pipetted onto the dorsal surface of
each ear at 24-h intervals for the durations indicated. Purified
azide-free anti-mouse TLR4/MD2 (clone MTS/510; BioLegend,
San Diego, CA) or rat IgG2a isotype control antibodies
(BioLegend) were diluted in phosphate-buffered saline (PBS, pH
7.4; USP grade) and injected intraperitoneally (200–250lg/injec-
tion) at 2- or 3-day intervals as indicated.
Cell isolation
Lymph nodes
Superficial cervical (auricular) lymph nodes (LN) were collected,
homogenized between frosted microscope slides, and viable cell
counts performed on a Cellometer according to acridine orange/
propidium iodide staining (Nexcelom, Lawrence, MA). The LN
cells (5 105) were then seeded into 96-well U-bottom plates with
soluble anti-CD3 (5lg/ml) and anti-CD28 (2lg/ml) in complete
RPMI media containing L-glutamine and HEPES (Cellgro, Manassas,
VA) and supplemented with 7.5% fetal bovine serum (Hyclone,
Logan, UT), 50lM 1-mercapto-ethanol and penicillin-streptomycin
(Sigma, St. Louis, MO). Cells were then incubated at 37 C for 24 h
in a humidified 5% CO2/95% air incubator before well supernatants
were harvested and analyzed for cytokine expression using
Flowcytomix bead assay kits (formerly eBioscience, San Diego, CA).
Ears
One ear from each mouse was mechanically disrupted on a
TissueLyser II in digestion media containing collagenase and
DNase (STEMCELL Technologies, Vancouver, Canada).
Homogenized tissues were then digested in a shaking 37 C water-
bath (45min). Tissues were then processed through 70-lm cell
strainers and re-suspended in complete RPMI media. After counting,
aliquots (2 105 cells) were seeded into wells of 96-well U-bottom
plates and incubated for 24h in a 5% CO2–95% air humidified
incubator.
Ear protein analyses
One ear per mouse was mechanically disrupted using a
TissueLyser II (Qiagen, Valencia, CA) in T-PER protein extrac-
tion reagent (Thermo Fisher, Grand Island, NY). The soluble
protein fraction was collected and quantified by BCA protein
assay (Thermo Fisher).
SDS-Page and Western blotting
For SDS-PAGE, 50 lg protein from each sample and Precision
Plus ProteinTM All Blue Prestained Protein Standards (Bio-Rad,
Hercules, CA) were separated over 15% polyacrylamide gels and
detected with ImperialTM protein stain (Bio-Rad). For Western
blotting analyses, ear tissue proteins (5lg/lane) were separated by
SDS-PAGE and transferred overnight onto nitro-cellulose mem-
branes. The membranes were then incubated in Tris-buffered
saline (TBS) blocking buffer containing 0.05% Tween-20 and 5%
dry milk to mitigate nonspecific inter-actions. Thereafter, mem-
branes were incubated with either anti-mouse S100A8 antibody or
anti-mouse S100A9 antibody (R&D Systems, Minneapolis, MN) at
a manufacturer-recommended concentration of 1lg/ml blocking
buffer. Membranes were then washed in TBS buffer containing
0.05% Tween-20 and incubated with anti-rat horseradish peroxid-
ase (HRP) antibody (R&D Systems; 1:1000 dilution in blocking
buffer). Ultimately, the membranes were developed using ECLTM
Western blotting detection reagents (GE Healthcare, Pittsburgh,
PA) and immunoreactive bands then detected by exposing the
membranes to CL-XPosureTM film (Thermo Fisher).
Mass spectrometry
Select protein bands were first excised from SDS-PAGE gels.
Spots were de-stained, reduced, alkylated and digested with por-
cine trypsin (Sigma) according to the method of by Shevchenko
et al. (2006). Specifically, digested proteins were subjected to
ultra-performance liquid chromatography (UPLC) on a
nanoAcquity system (Waters, Milford, MA). Eluent from the
nanoUPLC system was directed to the positive nanoelectrospray
(þnanoESI) source of a Synapt quadrupole time-of-flight mass
spectrometer (qTOF MS). Multiplexed tandem mass spectra were
then acquired in “MSe” fashion and data were analyzed using
ProteinLynx Global Server v 2.5.1 (Waters, Milford, MA) to
search the entire non-redundant SwissProt protein database
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(www.uniprot.org). The search was constrained by using 20 ppm
mass accuracy (m/Dm), carbamidomethyl cysteine as a fixed
modification, trypsin as enzyme and a minimum of two peptides
to match. Unmatched de novo peptide sequences were scanned
against SwissProt using the PAM30MS scoring matrix.
Luminex
For this assay, 25 lg tissue lysate or supernatants of leukocytes iso-
lated from the ear tissue (diluted 1:5) were analyzed for S100A8
and S100A9 expression by a luminex assay according to manufac-
turer instructions (R&D Systems) on a Luminex 200 system
(Millipore, Billerica, MA). Results are presented as mean fluores-
cence intensity (MFI) for tissue lysates or pg/ml for supernatants.
RT-PCR
Tissues were mechanically disrupted on a TissueLyser II in
Buffer RLT (ears) or Qiazol (LN) (Qiagen, Valencia, CA). Total
RNA was extracted using Qiagen RNeasy mini-spin column kit
with DNase treatment (ears) or a Qiagen miRNeasy kit (LN) on
a QIAcube work station. RNA levels and purity were analyzed
on a NanoDrop spectrophotomer (Thermo Fisher). The cDNA
(1–2 lg) was prepared on an Eppendorf Mastercycler using a
High Capacity Reverse Transcription kit (Thermo Fisher). The
cDNA was used as template for real-time PCR reactions contain-
ing TaqMan PCR Master Mix with gene-specific primers
(Thermo Fisher) on a 7500 Real-Time PCR System (Thermo
Fisher). Relative fold-gene expression changes (2DDCT) was
determined compared to acetone controls unless otherwise indi-
cated and normalized for expression of housekeeping gene Actb.
Flow cytometry
Cells were re-suspended in staining buffer (PBS þ1% bovine
serum albumin þ0.1% sodium azide) containing Fc receptor
blocking antibody anti-mouse CD16/32 (clone 2.4G2; BD
Biosciences, San Jose, CA). Cells were next suspended in staining
buffer containing fluorochrome-conjugated antibodies recogniz-
ing cell surface epitopes in different combinations that included:
CD45-Allophycocyanin, CD8-V500 (BD Biosciences), CD45R-
Alexa FluorVR 488, MHC II-Alexa FluorVR 700, CD11b-PerCP-
Cy5.5 (eBioscience, San Diego, CA), CD4-Brilliant Violet 421VR ,
TLR4-Phycoerythrin and IL-4Ra-Phycoerythrin (BioLegend, San
Diego, CA). Cells were then washed in staining buffer and fixed
in Cytofix Buffer (BD Biosciences). For intracellular Phospho-
STAT6-Phycoerythrin staining, cells were first cultured in com-
pete media for 90min with or without recombinant interleukin
(IL)-4 (5 ng/ml; BD Biosciences) and then immediately fixed in
Phos-flow fix buffer (37 C) for 15min and permeabilized over-
night in Perm Buffer III (20C) (BD Biosciences) prior to stain-
ing. For each evaluation, 100,000 events were analyzed on an
LSR II flow cytometer (BD Biosciences). Compensation controls
were prepared with OneComp eBeads (eBioscience). All data
analyzes were performed using FlowJo 7.6.5 software (TreeStar
Inc., Ashland, OR).
Statistical analyses
One- or two-way analysis of variance (ANOVA) of log-trans-
formed data followed by Fisher’s Least Significant Difference
(LSD) or Tukey’s HSD post-hoc tests were performed as indicated
using JMP software (SAS Institute, Cary, NC) with an a level of
0.05. All data shown are the means ± SEM.
Results
Repeated topical application of triclosan induces S100A8/A9
expression in skin tissue
Proteins in the soluble fractions of lysates prepared from ear tis-
sue of mice treated daily for 10 days with acetone control or 3%
triclosan and resolved them by SDS-PAGE gel electrophoresis
were evaluated for initial investigations into the innate immune
factors with repeated exposures. An abundant protein band with
an approximate molecular mass of 13 kDa was identified in the
skin tissue of triclosan-treated mice (Figure 1(A), black rect-
angle). Tandem mass spectrometric analysis identified this band
to be calcium-binding protein S100A9. Two immunoreactive bands
were further resolved by Western blot analysis for S100A9, likely
reflecting different post-translational modifications (Figure 1(B)).
A third band was also detected at 27 kDa, the predicted size of
intact S100A9 homodimers or heterodimer. As S100A9 can form
heterodimers with S100A8, immunoblotting for S100A8 revealed a
band of the expected 10 kDa size in triclosan-treated mice. These
results demonstrate that repeated topical skin application of triclo-
san can induce the expression of S100A8/A9 proteins.
Expression kinetics of S100A8/A9 in the skin tissue during
repeated triclosan exposure was next evaluated. S100a8 and
S100a9 transcripts were measured over the course of 12 days of
Figure 1. Repeated topical application of triclosan induces the expression of S100A8 and S100A9 in skin tissue. (A) Protein standards (first lane) and protein lysates
prepared from ear tissues (n¼ 4 mice) treated with 0% (acetone) control (lanes 1–4) or 3% triclosan (lanes 5–8) once daily for 10 days. (B) Western blot analysis of
S100A8 and S100A9 proteins in ear tissue.
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daily topical application of 0%, 0.75% or 3.0% triclosan. Both
S100a8 and S100a9 transcripts were significantly increased by
Day 4 (3%) or Day 6 (0.75%) in triclosan-treated mice compared
to in 0% acetone controls. Relative levels of transcript continued
to increase dose-dependently over time, peaking at levels>1000-
fold for the 3% dose [compared to 0% acetone control] by Day 9
(Figure 2(A)). These effects were limited to the skin as we were
not able to detect increases in S100a8 or S100a9 in the blood of
mice exposed to triclosan at any time point (data not shown).
LuminexVR multiplex analysis of soluble proteins extracted from
the ear tissue revealed S100A8/A9 protein expression was already
significantly increased in the skin after only four days of 3% tri-
closan exposure (Figure 2(B)) and remained significantly elevated
through Day 12.
Leukocytes, isolated from skin tissue, were evaluated to deter-
mine if infiltrating cells were responsible for the increased expres-
sion observed at the early timepoints. Approximately half of the
cells recovered were determined to be neutrophils (CD11bþLy6gþ)
after eight days of 3% triclosan exposure (data not shown). After
24 h of ex vivo culture, dose-dependent increases in S100A8 and
S100A9 proteins were detected in supernatants (Figure 2(C)), sug-
gesting infiltrating leukocytes are one of the sources of S100A8/9 in
skin tissue during repeated triclosan exposure.
Changes in TLR expression in skin tissue with repeated
triclosan exposure
Expression kinetics of TLR in skin tissue were examined as the
S100A8/A9 heterodimer has been described to act as an
endogenous ligand for TLR4 (Figure 3(A)). Interestingly, the
family of surface receptors that recognize bacterial ligands
including Tlr1, Tlr2, Tlr4 and Tlr6 had similar expression kinet-
ics, with significant increases over time with 3% triclosan expos-
ure relative to acetone control. Small but significant increases in
Tlr2 expression was also observed at the 0.75% concentration.
Although some significant changes in gene expression following
triclosan exposure were observed, the expression kinetics were
different for the endosomal nucleic-acid sensing family of TLRs
(TLR3, TLR7, TLR8, TLR9) suggesting these were differentially
regulated in the skin tissue compared to the cell surface family of
TLR. TLR4 was also highly expressed on skin-infiltrating
CD45þ leukocytes, including neutrophils, with significant
increases in expression following exposure to 3% triclosan
(Figure 3(B)). No increases in TLR2 expression on leukocytes
were detected and the expression of TLR4 and TLR2 were not
increased on cells in the LN or spleen (data not shown).
TLR4/MD-2 antibody blockade decreases early inflammatory
responses in skin with dermal triclosan exposure
Since robust increases in S100A8/A9 and TLR4 expression were
identified, it was further investigated whether the TLR4 pathway
was mediating immunomodulatory effects with repeated triclosan
exposure. A blocking antibody that recognizes TLR4 and associ-
ated MD-2 molecule or an isotype control was administered dur-
ing topical application of 0% or 3% triclosan (Figure 4(A)). The
3% dose was selected for these evaluations since the majority of
changes were identified at this concentration. On Day 5, effects of
triclosan and anti-TLR4/MD2 on molecular and cellular responses
in the skin and LN were examined. Following four days of repeated
triclosan exposure transcript levels of select Tlr and S100a8 and
Figure 2. Expression kinetics of S100A8 and S100A9 in the skin tissue with repeated topical application of triclosan. (A) Relative fold-changes in gene expression in
cDNA prepared from ear tissue of mice dosed daily with 0.75% (square) or 3% (triangle) triclosan relative to acetone control (n¼ 4 mice). (B) Mean fluorescence inten-
sity of S100A8 and S100A9 protein expression in ear tissue of mice dosed daily with 0% (circle), 0.75% (square) or 3% (triangle) triclosan (n¼ 4–6 mice). (C)
Concentrations of soluble proteins in supernatants from leukocytes extracted from ear skin tissue of mice dosed eight consecutive days with 0, 0.75, or 3.0% triclosan
and cultured ex vivo for 24 h (n¼ 3–5 mice). ANOVA with Fisher’s LSD statistical analyses were performed; significant differences relative to 0% indicated as p< .05,p< .01, p< .001.
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S100a9 were starting to increase, therefore the Day 5 timepoint
was selected to evaluate early immunomodulatory effects.
Repeated triclosan application induced significant increases in
pro-inflammatory cytokines in the skin, including Tslp, Il1b, Il6
and Tnfa, with no significant effects on Il25 or Il33 relative to
control (Figure 4(B)). Of these, Il6, S100a8, S100a9 and Tlr2
were significantly reduced after TLR4/MD-2 blockade compared
to isotype control along with the loss of significant increases in
Tnfa expression compared to acetone control. The expression of
Tlr1, Tlr4 and Tlr6 were also no longer significantly increased
relative to acetone control after TLR4/MD-2 blockade. Taken
together, these results suggested that expression of the bacterial-
sensing surface TLR family of receptors could be partially regu-
lated through TLR4 signaling in skin tissue and that activation of
the TLR4 pathway promoted early pro-inflammatory responses
in skin tissue during triclosan exposure.
TLR4/MD-2 antibody blockade decreases early TH2 cytokine
responses in LN with dermal triclosan exposure
Local draining LN was also examined to determine whether
TLR4/MD-2 antibody blockade impaired localized immune
responses induced with repeated triclosan application. A signifi-
cant decrease in total LN cellularity for triclosan-exposed mice
with anti-TLR4/MD-2 treatment compared to isotype control
was identified (Figure 5(A)). Additional phenotyping revealed the
significant decreases were not unique to one particular cell type
as there were no changes in frequencies of different cell subsets
(data not shown) and numbers of CD4 T-cells, CD8 T-cells, B-
cells and dendritic cells (DC) were all significantly decreased
with TLR4/MD-2 blockade (Figure 5(B)).
LN T-cells were also stimulated ex-vivo to reveal effects of tri-
closan and anti-TLR4/MD-2 blockade on T-cell cytokine produc-
tion. Early significant increases in IL-2, -6 and -17 production
following triclosan exposure were not affected by TLR4/MD-2
blockade (Figure 5(C)). Additional phenotyping revealed low
CD67L and CCR7 expression on the T-cells (data not shown),
suggesting the population consists of a heterogeneous mixture of
primary effectors and effector memory T-cells of unknown anti-
gen specificities. At this Day 5 timepoint, IL-4 and IL-13 were
significantly increased at the transcript level with triclosan expos-
ure and interestingly, the levels of IL-4 transcript and IL-13 tran-
script and protein were significantly decreased with TLR4/MD-2
blockade (Figure 5(C, D)). Other cytokines including interferon
(IFN)-c, IL-5, IL-10 and tumor necrosis factor (TNF)-a were
Figure 3. Changes in TLR expression in the skin and infiltrating leukocytes with repeated topical application of triclosan. (A) Relative fold changes in gene expression
in cDNA prepared from ear tissue of mice dosed daily with 0.75% (square) or 3% (triangle) triclosan relative to acetone control (n¼ 4 mice). (B) Mean fluorescence
intensity of TLR4 expression on CD45þ cells isolated from ear tissue of mice dosed eight consecutive days with 0% (white), 0.75% (gray), or 3.0% (black) triclosan (B,
left) (n¼ 3–5 mice). Representative staining histogram of TLR4 expression on CD45þ cells isolated from ear tissue of mice dosed daily for eight consecutive days with
triclosan, 0% (gray), 0.75% (dotted), 3.0% (black) and isotype staining control (gray filled) (B, right). Two-way ANOVA with Fisher’s LSD statistical analyses were per-
formed; significant differences relative to 0% indicated as p< .05, p< .01, p< .001.
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also produced by LN T-cells but were not significantly affected
by triclosan exposure or TLR4/MD-2 blockade (data not shown).
The phenotype of LN antigen-presenting cells was also exam-
ined. No differences in the expression of co-stimulatory markers
CD80 and CD86 or MHC II on B-cells and DC were noted with
TLR4/MD-2 blockade (data not shown). As the expression levels
of IL-4 and IL-13 were significantly decreased, expression of their
shared receptor subunit IL-4Ra was also examined. There was a
small but significant decrease in IL-4Ra expression on DC with
TLR4/MD-2 blockade, but no effect on expression on B-cells or
CD4 T-cells was observed (Figure 5(E)). As shown in Figure 5(F),
LN cells from triclosan-exposed mice pulsed with IL-4 expressed
increased levels of phosphorylated-STAT6 which is activated
downstream of IL-4Ra. Levels of phosphorylated STAT6 were
equal to that of control cells suggesting that while blocking TLR4
signaling decreased the production of IL-4 and IL-13 in the LN,
the cognate receptor signaling pathway was not impaired.
Impaired TH2 cytokine responses are sustained during
extended triclosan dosing and TLR4/MD-2 blockade
Next, the effects of extended subchronic triclosan dosing with
TLR4/MD-2 blockade were examined to determine whether the
effects on the skin and LN could be sustained. Both an acetone
control- and triclosan-treated group of mice received anti-TLR4/
MD-2 antibody to control for any effects of extending blocking
activity of TLR4. Mice were dosed for nine consecutive days with
blocking antibody administered every third day (Figure 6(A)).
Blocking TLR4/MD-2 in acetone control mice did not produce
Figure 4. TLR4/MD-2 antibody blockade impairs gene expression changes in skin tissue with repeated topical application of triclosan. (A) Timeline depicting adminis-
tration of antibodies and topical application of triclosan to the mice. (B) Relative fold-changes in gene expression in cDNA prepared from ear tissue on Day 5 from
mice treated with 3% triclosan/isotype control antibody (gray) or 3% triclosan/anti-TLR4/MD-2 (black) relative to acetone control (white) (n¼ 5 mice). ANOVA with
Tukey’s HSD statistical analyses were performed; significant differences indicated as p< .05, p< .01, p< .001.
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any measurable effects. Interestingly, the differences in gene
expression in the skin tissue of the triclosan-treated mice that
received anti-TLR4/MD-2 compared to isotype control on Day 5
(Figure 4(B)) were no longer detected at Day 10 (Supplementary
Figure 1A).
Examination of the LN at Day 10 revealed that the decreased
cellularity with anti-TLR4/MD-2 treatment had also rebounded
to equal numbers as isotype control in triclosan-exposed mice
(Figure 6(B)), with no significant changes in frequencies or num-
bers of the LN cell subsets (data not shown). When the LN T-
cells were stimulated ex vivo, the concentrations of IL-4, -13 and
-17 in the supernatants were significantly elevated relative to
acetone control (Figure 6(C)). Remarkably, the amounts of IL-4
and IL-13 produced by LN T-cells from triclosan-exposed mice
still remained decreased after TLR4/MD-2 blockade (Figure 6(C)).
Taken together, although early responses in skin and LN during
triclosan exposure were impaired with TLR4/MD-2 blockade, these
effects eventually rebound with the exception of impaired TH2
cytokine production that continued to persist.
Discussion
The goal of these studies was to identify innate immune factors
induced in skin tissue with repeated triclosan exposure that may
Figure 5. TLR4/MD-2 antibody blockade impairs immune responses in the local LN during repeated topical application of triclosan. Numbers of (A) viable cells and (B)
leukocyte subsets collected from the LN of mice Day 5 treated with acetone/isotype (square), 3% triclosan/isotype (triangle) or 3% triclosan/anti-TLR4/MD-2 (circle)
(n¼ 5 mice). (C) Concentrations of cytokines in supernatants from LN cells cultured 24 h ex vivo with anti-CD3/CD28. (D) Relative fold-changes in gene expression in
cDNA prepared from ear tissue of mice treated with 3% triclosan/isotype control antibody (gray) or 3% triclosan/anti-TLR4/MD-2 (black) relative to acetone control
(white). (E) Mean fluorescence intensity of IL-4Ra expression on LN leukocyte subsets. (F) Intracellular phosphorylated STAT6 expression in LN cells from mice treated
with acetone/isotype (square), 3% triclosan/isotype (triangle) or 3% triclosan/anti-TLR4/MD-2 (circle) pulsed with IL-4 (5 ng/ml) (gray) or without (white). ANOVA with
Fisher’s LSD statistical analyses were performed; significant differences indicated as p< .05, p< .01, p< .001.
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contribute to previously identified immunomodulatory responses.
Large increases in S100A8/A9 protein expression – most likely
due to infiltrating neutrophils along with de novo synthesis in
the skin – were identified. S100A8/A9 protein expression
increased very early before elevated transcript was measured sug-
gesting infiltrating cells, in addition to local production were
potential sources. Although keratinocytes are a known source of
S100A8/A9, cells of myeloid lineage can constitutively express it
and neutrophils were previously found to be a major cellular
infiltrate in the triclosan-exposed mouse ear skin tissue (Marshall
et al. 2015). Significant increases in S100A8/A9 expression with
application of 0.75% triclosan, a concentration within the range
found in consumer products (0.03–1.0%) was identified. Our
studies previously found that repeated application of 0.75% tri-
closan did not cause overt irritation to the skin as can occur
transiently with 3% triclosan (Marshall et al. 2015); yet, despite
this, S100A8 and S100A9 expression reached similar levels with
exposure to both concentrations. It should be noted that in add-
ition to dermal exposure, there is also the potential for oral
exposure. Studies conducted by Fang et al. (2016) estimated
using Elizabethan collars that 20% of a triclosan dermal dose was
absorbed through oral exposure as a result of grooming.
Generally, S100A8/A9 is expressed at low levels in healthy epi-
dermis but expression can be induced by disruptions of the skin
barrier (Eckert et al. 2004). It is highly up-regulated in skin tissue
after exposure to solar radiation, repeated Vaseline application or
tape stripping (Marionnet et al. 2003). S100A8/A9 is a well char-
acterized biomarker of inflammation (Ehrchen et al. 2009;
Schiopu & Cotoi 2013); however, transgenic mice over-expressing
activin A have high levels of S100A8/A9 in the epidermis in the
absence of inflammation (Thorey et al. 2001). S100A8/A9 is
thought to play an important role in skin diseases including
Figure 6. The effects of TLR4/MD-2 antibody blockade on the LN with extended triclosan dosing. (A) Timeline depicting administration of antibodies and topical appli-
cation of triclosan to the mice. (B) Numbers of viable cells collected from the LN of mice Day 10 treated with acetone/isotype (square), acetone/anti-TLR4 (triangle),
3% triclosan/isotype (circle) or 3% triclosan/anti-TLR4 (inverted triangle) (n¼ 4–6 mice). (C) Concentrations of cytokines in supernatants from LN cells cultured ex vivo
for 24 h with anti-CD3/CD28. Two-way ANOVA with Fisher’s LSD post-hoc statistical analyses were performed; significant differences are indicated as a 6¼ b where
p< .05 and p< .001.
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psoriasis and lichen planus but is not associated with other skin
conditions such as atopic dermatitis, uticaria, or granuloma
annulare (Loser et al. 2010). Thus, expression of S100A8/A9 in
skin tissue does not appear to be a prerequisite for inflammation
– nor is it expressed with all inflammatory skin conditions, sug-
gesting it may be involved in the immunomodulatory activity
induced following dermal exposure to certain agents like triclo-
san that can act as allergic immune adjuvants.
The present study found that impairing TLR-4/MD-2 activity
with in vivo administration of blocking antibody suppressed early
responses in the skin tissue during triclosan exposure, including
decreases in the expression of the cytokines Il-6 and Tnf-a.
Induction of IL-6 and TNFa along with increases in cell prolifer-
ation have also been observed in human keratinocytes stimulated
with S100A8/A9 (Nukui et al. 2008). Tlr1, Tlr2, Tlr4 and Tlr6
showed similar expression kinetics with repeated topical applica-
tion of triclosan, and blocking TLR4 signaling impaired their
expression on Day 5 of exposure. These data suggested that regu-
lation of this family of bacteria-sensing surface receptors was
closely connected and controlled in part through the TLR4 recep-
tor signaling pathway. The lack of expression changes at sites
other than the skin, suggested factors unique to the environment
at the site of triclosan application promoted the recruitment of
TLR4þ leukocytes and induce expression of TLR4 in the skin
tissue.
With the robust increases in S100A8/A9, we postulate this is
likely an important endogenous ligand activating the TLR4 path-
way. Further, although significant increases in Tlr4 expression at
the 0.75% dose were not observed, given that TLRs are constitu-
tively expressed in dermal tissue, the robust increases in S100A8/
A9 at this dose would still likely engage the TLR4 signaling path-
way. Other endogenous ligands of TLR4 have been described
including high mobility group box 1 (HMGB1) (Park et al. 2004)
and methyl-CpG binding domain protein 2 (mBD2) (Biragyn
et al. 2002). Thus, we cannot rule out that blocking TLR4 inter-
actions with other ligands may also be producing immunomodu-
latory effects as well.
It is important to consider that commensal bacteria that
inhabit the skin can be stripped away with exposure to antimi-
crobials. In mice, gram-negative bacteria represent a large por-
tion of the commensal skin population that can be recognized by
TLR4, along with populations of gram-positive bacteria that can
be recognized by TLR2. Skin commensals can interact with the
immune system (Naik et al. 2012); as such, alterations of the skin
microbiome may produce immunomodulatory effects.
Interestingly, allergic contact hypersensitivity (CHS) induced by
2,4,6-trinitro-1-chlorobenzene (TNCB) was shown to be amelio-
rated in the concomitant absence of TLR2 and TLR4 as well as
IL-12Rb2 and TLR4 but not in the absence of TLR4 alone
(Martin et al. 2008). To determine a role for interactions with
commensal bacteria, TNCB was then applied to the skin of
germ-free (GF) mice which showed that CHS was induced in
both wild-type GF mice as well as IL-12Rb2/ GF mice, but not
in double-deficient TLR4/ IL-12Rb2/ GF mice. This sug-
gested an important role for interactions with endogenous
ligands like S100A8/A9 in promoting CHS even in the absence
of skin commensals.
Here, by Day 10, measurable differences in gene expression in
the skin tissue after TLR4/MD-2 blockade compared to isotype
control were no longer detected in triclosan-exposed mice. The
loss of these effects suggests engagement of alternative and/or
redundant receptor pathways are eventually sufficient to mediate
the responses induced by repeated triclosan exposure. While
some of the extracellular functions of S100A8/A9 are mediated
through TLR4, effects have also been described through the
engagement of the receptor for advanced glycation end-products
(RAGE) which activates the MAP Kinase/NF-jB pathway (Zhong
et al. 2015). In the skin, although levels of Rage were not affected
by TLR4 blockade, relative levels of transcript eventually
increased four-fold by Day 12 in triclosan-treated mice
(Supplementary Figure 1B). However, a role for RAGE in the
responses to triclosan has not yet been identified. Other pathways
may also be activated. S100A9-induced airway inflammation in
mice for example, was reported to occur independent of both
RAGE and TLR4 signaling (Chen et al. 2015). Thus, the roles for
the S100A8/A9-TLR4 axis in the modulation of immune
responses are still not fully understood.
The present study found that engagement of the TLR4/MD-2
receptor helped to augment early inflammatory responses in the
skin tissue as well as increases in IL-4 and IL-13 production by
T-cells in the LN of triclosan-exposed mice. These findings pro-
vide additional insight into the immunomodulatory mechanisms
of action following topical exposure to triclosan and suggest that
components of the S100A8/A9-TLR4 pathway may be involved
in previously-observed immune adjuvancy effects.
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